Evidence map›Paper›PMID 20072628›Full record

ArticlePloS one2010

A novel TCR transgenic model reveals that negative selection involves an immediate, Bim-dependent pathway and a delayed, Bim-independent pathway.

Damian Kovalovsky, Mark Pezzano, Benjamin D Ortiz, Derek B Sant'Angelo

Abstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. T Cells and Regulated Cell Death: Kill or Be Killed.International review of cell and molecular biology · 2019
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. NF-κB control of T cell development.Nature immunology · 2014
    Review
  10. Article
  11. Murine thymic selection quantified using a unique method to capture deleted T cells.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  12. Article
  13. Article
  14. T-cell tolerance: central and peripheral.Cold Spring Harbor perspectives in biology · 2012
    Article
  15. Article
  16. Article
  17. Review
  18. Proapoptotic protein Bim is differentially required during thymic clonal deletion to ubiquitous versus tissue-restricted antigens.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  19. Review
  20. Functional development of the T cell receptor for antigen.Progress in molecular biology and translational science · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Damian KovalovskyImmunology Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Mark Pezzano
Benjamin D Ortiz
Derek B Sant'Angelo

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024996 · NCRR · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2007 to 2011
$49.6M
WILD TYPE &MUTANT P53 INTERACTIONS WITH HIV LTR DNAG12RR003037 · NCRR · HUNTER COLLEGE · PI DOTTIN, ROBERT P · 1985 to 2011
$27.6M
Cellular/Molecular Basis of Development: Research CenterG12MD007603 · NIMHD · CITY COLLEGE OF NEW YORK · PI PEZZANO, MARK · 2012 to 2017
$11.5M
IMMUNOLOGY RESEARCH TRAININGT32CA009149 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI RUDENSKY, ALEXANDER Y · 1985 to 2022
$4.0M
Pilot--Religious comfort /strain in low income cancerU56CA096299 · NCI · CITY COLLEGE OF NEW YORK · PI HUBBARD, KAREN · 2002 to 2007
$2.5M
Development and Maintenance of Thymic Epithelial MicroenvironmentsSC1AI104994 · NIAID · CITY COLLEGE OF NEW YORK · PI PEZZANO, MARK · 2012 to 2015
$1.4M
Crosstalk Control of Thymic Epithelial DevelopmentSC1AI081527 · NIAID · CITY COLLEGE OF NEW YORK · PI PEZZANO, MARK · 2008 to 2011
$1.1M
NCI NIH HHS P30 CA008748NCI NIH HHS P30-CA 08748NCI NIH HHS T32 CA009149NCI NIH HHS T32-CA-09149-32NCI NIH HHS U56 CA096299NCI NIH HHS U56 CA96299NCRR NIH HHS G12 RR003037NCRR NIH HHS G12RR0360NCRR NIH HHS RR003037NCRR NIH HHS UL1 RR024996NCRR NIH HHS UL1RR024996NIAID NIH HHS 1SC1AI081527NIAID NIH HHS SC1 AI081527NIAID NIH HHS SC1 AI104994NIMHD NIH HHS G12 MD007603
6 · The paper itself

Abstract

A complete understanding of negative selection has been elusive due to the rapid apoptosis and clearance of thymocytes in vivo. We report a TCR transgenic model in which expression of the TCR during differentiation occurs only after V(D)J-like recombination. TCR expression from this transgene closely mimics expression of the endogenous TCRalpha locus allowing for development that is similar to wild type thymocytes. This model allowed us to characterize the phenotypic changes that occurred after TCR-mediated signaling in self-reactive thymocytes prior to their deletion in a highly physiological setting. Self-reactive thymocytes were identified as being immature, activated and CD4(lo)CD8(lo). These cells had upregulated markers of negative selection and were apoptotic. Elimination of Bim reduced the apoptosis of self-reactive thymocytes, but it did not rescue their differentiation and the cells remained at the immature CD4(lo)CD8(lo) stage of development. These cells upregulate Nur77 and do not contribute to the peripheral T cell repertoire in vivo. Remarkably, development past the CD4(lo)CD8(lo) stage was possible once the cells were removed from the negatively selecting thymic environment. In vitro development of these cells occurred despite their maintenance of high intracellular levels of Nur77. Therefore, in vivo, negatively selected Bim-deficient thymocytes are eliminated after prolonged developmental arrest via a Bim-independent pathway that is dependent on the thymic microenvironment. These data newly reveal a layering of immediate, Bim-dependent, and delayed Bim-independent pathways that both contribute to elimination of self-reactive thymocytes in vivo.

Indexed as

AnimalsApoptosisApoptosis Regulatory ProteinsBcl-2-Like Protein 11CD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFemaleFlow CytometryMaleMembrane ProteinsMiceMice, TransgenicProto-Oncogene ProteinsReceptors, Antigen, T-CellThymus GlandApoptosis Regulatory ProteinsBcl2l11 protein, mouseBcl-2-Like Protein 11Membrane ProteinsProto-Oncogene ProteinsReceptors, Antigen, T-Cell

Identifiers

PMID20072628
PMCPMC2800196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.